2 Marijuana Stocks Better Than Aurora Cannabis

Here’s why marijuana producers such as Green Thumb and Jushi Holdings are better than Aurora Cannabis right now.

| More on:
Cannabis stocks have fallen.

While markets were trading near record highs at the end of 2021, several Canadian marijuana stocks, such as Aurora Cannabis (TSX:ACB)(NYSE:ACB), underperformed broader indices. At the time of writing, ACB stock is down 94% from all-time highs, burning massive investor wealth in the process.

Aurora Cannabis outlined a business transformation plan in 2020 to reduce manufacturing capacity and lower its cost structure. However, in this period, the cannabis producer has derived cost savings of just $60 million while its operating loss in the last 12 months is close to $270 million. Comparatively, its net loss is much higher at $604.1 million in the last four quarters.

Further, the Canadian marijuana market continues to expand, but Aurora Cannabis saw its quarterly revenue shrink by almost 2% in the last three years.

In order to offset its cash-burn rates, Aurora Cannabis raised equity capital multiple times in the last three years, which accelerated shareholder dilution. The company also disclosed it will exit the recreational marijuana market to focus on the higher-margin medical marijuana segment.

Given its market cap of $1.02 billion, ACB stock is valued at a forward price-to-fiscal-2022-sales multiple of 4.3 times, which is quite expensive for a loss-making entity with weak fundamentals. Let’s take a look at two marijuana stocks better than Aurora Cannabis.

Green Thumb Industries

One of the largest cannabis companies in the world, Green Thumb Industries (CNSX:GTII) operates 75 dispensaries with licences to open 114 more retail locations in 14 markets south of the border.

As most states are likely to legalize the consumption of recreational marijuana in the U.S., Green Thumb is well poised to take advantage of a rapidly expanding addressable market. In the third quarter of 2021, the company reported revenue of US$233.7 million — an increase of 49% year over year.

It also reported a net income of US$20.8 million, which was Green Thumb’s fifth consecutive quarter of profitability. In the year-ago period, its net income stood at US$9 million.

Green Thumb ended 2019 with 40 stores and has almost doubled in size in the last two years. It opened 15 new stores in 2021 that allowed it to increase revenue as well as profits at an enviable pace.

Jushi Holdings

A small-cap cannabis stock valued at a market cap of $945 million, Jushi Holdings (CNSX:JUSH) is down 57% from all-time highs. The company more than doubled its sales to US$54 million in Q3 of 2021, while adjusted EBITDA surged higher by 129% year over year to US$6.4 million.

Jushi ended Q3 with 26 operating dispensaries in six U.S. states. Its acquisition of NuLeaf will also provide Jushi with additional stores in Nevada — one of the largest cannabis markets in the country.

In Q3, close to 80% of total sales were derived from the online channel where the average cart size stood at US$122. Jushi confirmed its online conversion rate stood at 14%, which is much higher than the 3% figure for e-commerce.

Analysts tracking Jushi stock have a 12-month average price target of US$6.91 per share, which is 87% above its current trading price.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Aditya Raghunath has no position in any of the stocks mentioned. The Motley Fool recommends Green Thumb Industries. The Motley Fool owns and recommends Jushi Holdings.

More on Cannabis Stocks

edit Jars of marijuana
Cannabis Stocks

Is Tilray Stock a Buy in the New Bullish Market?

Canadian cannabis producer Tilray has underperformed the broader markets in the last five years due to its weak fundamentals.

Read more »

Bad apple with good apples
Cannabis Stocks

1 TSX Stock I Wouldn’t Touch With a 10-Foot Pole

Down 99% from all-time highs, Aurora Cannabis stock remains a high-risk bet due to its weak fundamentals and risky liquidity…

Read more »

A cannabis plant grows.
Cannabis Stocks

Canopy Growth Stock Has Been on a Roller Coaster: Is it a Good Buy?

In their relatively small lifetime, most cannabis stocks in Canada have seen both extreme highs and massive slumps. But their…

Read more »

Medicinal research is conducted on cannabis.
Cannabis Stocks

Canopy Growth Stock Surged 100% Last Month: Is It a Good Buy Now?

Canopy Growth soared more than 160% last month. Can the TSX cannabis stock continue to mover higher in 2024?

Read more »

A cannabis plant grows.
Cannabis Stocks

Canopy Growth Stock Is Rising But I’m Worried About This One Thing

Canopy Growth stock is soaring as the legalization effort makes real progress in both Germany and the United States.

Read more »

Cannabis grows at a commercial farm.
Cannabis Stocks

Why Canopy Growth Stock Could Double in 2024

Canopy Growth (TSX:WEED) stock saw its share more than double in the last two weeks. So, can it do it…

Read more »

Coworkers standing near a wall
Cannabis Stocks

Why Is Everyone Talking About Canopy Growth Stock?

Canopy Growth stock (TSX:WEED) saw shares surge in the last two weeks for a variety of reasons investors can dig…

Read more »

Pot stocks are a riskier investment
Stocks for Beginners

Why Shares of Cannabis Stocks Are Rising This Week

Cannabis stocks received a boost this week as the White House urged the drug enforcement administration to reschedule the drug.

Read more »